Alzheimer’s Research Papers
Abe T, Tohgi H, Murata T, Isobe C, Sato C. Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett. 2001 Oct 26;312(3):177-9.
Sang H, Lu Z, Li Y, Ru B, Wang W, Chen J. Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules. Neurosci Lett. 2001 Oct 26;312(3):141-4.
Zhang L, Xing GQ, Barker JL, Chang Y, Maric D, Ma W, Li BS, Rubinow DR. Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway. Neurosci Lett. 2001 Oct 26;312(3):125-8.
Ma Q, Chan P, Yang J. [Association between DLST gene polymorphism and Alzheimer's disease] Zhonghua Yi Xue Za Zhi. 2001 Oct 25;81(20):1246-8.
Tanzi RE, Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 2001 Oct 25;32(2):181-4.
Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron. 2001 Oct 25;32(2):177-80.
Adair JC, Knoefel JE, Morgan N. Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease. Neurology. 2001 Oct 23;57(8):1515-7.
Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology. 2001 Oct 23;57(8):1461-6.
Borenstein Graves A, Mortimer JA, Bowen JD, McCormick WC, McCurry SM, Schellenberg GD, Larson EB. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology. 2001 Oct 23;57(8):1453-60.
Roos RA, Cruts M. [From gene to disease; presenilins and Alzheimer disease] Ned Tijdschr Geneeskd. 2001 Oct 20;145(42):2027-9.
Marx J. Alzheimer's disease. Bad for the heart, bad for the mind? Science. 2001 Oct 19;294(5542):508-9.
Boddeke EW. Involvement of chemokines in pain. Eur J Pharmacol. 2001 Oct 19;429(1-3):115-9.
Wang J, Tung YC, Wang Y, Li XT, Iqbal K, Grundke-Iqbal I. Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett. 2001 Oct 19;507(1):81-7.
Mikhailenko I, Battey FD, Migliorini M, Ruiz JF, Argraves K, Moayeri M, Strickland DK. Recognition of alpha 2-macroglobulin by the low density lipoprotein receptor-related protein requires the cooperation of two ligand binding cluster regions. J Biol Chem. 2001 Oct 19;276(42):39484-91.
Palacino JJ, Murphy MP, Murayama O, Iwasaki K, Fujiwara M, Takashima A, Golde TE, Wolozin B. Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion. J Biol Chem. 2001 Oct 19;276(42):38563-9.
Libeu CP, Lund-Katz S, Phillips MC, Wehrli S, Hernáiz MJ, Capila I, Linhardt RJ, Raffaï RL, Newhouse YM, Zhou F, Weisgraber KH. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J Biol Chem. 2001 Oct 19;276(42):39138-44.
Ermak G, Morgan TE, Davies KJ. Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. J Biol Chem. 2001 Oct 19;276(42):38787-94.
Morris HR, Schrag A, Nath U, Burn D, Quinn NP, Daniel S, Wood NW, Lees AJ. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Neurosci Lett. 2001 Oct 19;312(2):118-20.
Etcheberrigaray R, Ibarreta D. [Ionic channesls and second messenger alterations in Alzheimer s disease. Relevance of studies in non neuronal cells] Rev Neurol. 2001 Oct 16;33(8):740-9.
Fernández-Novoa L, Cacabelos R. Histamine function in brain disorders. Behav Brain Res. 2001 Oct 15;124(2):213-33.
Sun A, Nguyen XV, Bing G. A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease. J Neurosci Methods. 2001 Oct 15;111(1):17-27.
Golde TE, Eckman CB. Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease. Drug Discov Today. 2001 Oct 15;6(20):1049-1055.
Giubilei F, Patacchioli FR, Antonini G, Sepe Monti M, Tisei P, Bastianello S, Monnazzi P, Angelucci L. Altered circadian cortisol secretion in Alzheimer's disease: clinical and neuroradiological aspects. J Neurosci Res. 2001 Oct 15;66(2):262-5.
Chauhan NB, Siegel GJ, Lichtor T. Distribution of intraventricularly administered antiamyloid-beta peptide (Abeta) antibody in the mouse brain. J Neurosci Res. 2001 Oct 15;66(2):231-5.
Shelton SB, Johnson GV. Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells. J Neurosci Res. 2001 Oct 15;66(2):203-13.
Li Y, Liu L, Barger SW, Mrak RE, Griffin WS. Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res. 2001 Oct 15;66(2):163-70.
Zhang Y, Tounekti O, Akerman B, Goodyer CG, LeBlanc A. 17-beta-estradiol induces an inhibitor of active caspases. J Neurosci. 2001 Oct 15;21(20):RC176.
Andreasson KI, Savonenko A, Vidensky S, Goellner JJ, Zhang Y, Shaffer A, Kaufmann WE, Worley PF, Isakson P, Markowska AL. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci. 2001 Oct 15;21(20):8198-209.
Berger-Sweeney J, Stearns NA, Murg SL, Floerke-Nashner LR, Lappi DA, Baxter MG. Selective immunolesions of cholinergic neurons in mice: effects on neuroanatomy, neurochemistry, and behavior. J Neurosci. 2001 Oct 15;21(20):8164-73.
Watson JD. 11: disorders of memory and intellect. Med J Aust. 2001 Oct 15;175(8):433-9.
Anderson RN. Deaths: leading causes for 1999. Natl Vital Stat Rep. 2001 Oct 12;49(11):1-87.
Deuther-Conrad W, Loske C, Schinzel R, Dringen R, Riederer P, Münch G. Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism. Neurosci Lett. 2001 Oct 12;312(1):29-32.
Alonso AD, Zaidi T, Novak M, Barra HS, Grundke-Iqbal I, Iqbal K. Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J Biol Chem. 2001 Oct 12;276(41):37967-73.
Kins S, Crameri A, Evans DR, Hemmings BA, Nitsch RM, Gotz J. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J Biol Chem. 2001 Oct 12;276(41):38193-200.
Sobrido MJ, Cholfin JA, Perlman S, Pulst SM, Geschwind DH. SCA8 repeat expansions in ataxia: a controversial association. Neurology. 2001 Oct 9;57(7):1310-2.
Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12245-50.
Armstrong RJ, Barker RA. Neurodegeneration: a failure of neuroregeneration? Lancet. 2001 Oct 6;358(9288):1174-6.
Tsuchida K, Shioi J, Yamada S, Boghosian G, Wu A, Cai H, Sugahara K, Robakis NK. Appican, the proteoglycan form of the amyloid precursor protein, contains chondroitin sulfate E in the repeating disaccharide region and 4-O-sulfated galactose in the linkage region. J Biol Chem. 2001 Oct 5;276(40):37155-60.
Xie J, Chang X, Zhang X, Guo Q. Aberrant induction of Par-4 is involved in apoptosis of hippocampal neurons in presenilin-1 M146V mutant knock-in mice. Brain Res. 2001 Oct 5;915(1):1-10.
Kirkitadze MD, Condron MM, Teplow DB. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol. 2001 Oct 5;312(5):1103-19.
Helmuth L. Detangling Alzheimer's disease. Sci Aging Knowledge Environ. 2001 Oct 3;2001(1):oa2.
Honig LS, Chin SS. Alzheimer's disease. Sci Aging Knowledge Environ. 2001 Oct 3;2001(1):dn2.
Kheterpal I, Williams A, Murphy C, Bledsoe B, Wetzel R. Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. Biochemistry. 2001 Oct 2;40(39):11757-67.
Egnaczyk GF, Greis KD, Stimson ER, Maggio JE. Photoaffinity cross-linking of Alzheimer's disease amyloid fibrils reveals interstrand contact regions between assembled beta-amyloid peptide subunits. Biochemistry. 2001 Oct 2;40(39):11706-14.
Benussi L, Alberici A, Mayhaus M, Langer U, Ghidoni R, Mazzoli F, Nicosia F, Barbiero L, Frisoni G, Zanetti O, Gasparini L, Nitsch RM, Binetti G. Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: a release enhanced by apoptosis. Exp Cell Res. 2001 Oct 1;269(2):256-65.
Arango D, Cruts M, Torres O, Backhovens H, Serrano ML, Villareal E, Montañes P, Matallana D, Cano C, van Broeckhoven C, Jacquier M. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia. Am J Med Genet. 2001 Oct 1;103(2):138-43. ,
Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelsø C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nägga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem. 2001 Oct;47(10):1776-81.
Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davis RJ, Shirasaki Y, Greenberg ME. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci. 2001 Oct 1;21(19):7551-60.
Bontempi B, Whelan KT, Risbrough VB, Rao TS, Buccafusco JJ, Lloyd GK, Menzaghi F. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates. J Pharmacol Exp Ther. 2001 Oct;299(1):297-306.
Chan D, Crutch SJ, Warrington EK. A disorder of colour perception associated with abnormal colour after-images: a defect of the primary visual cortex. J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):515-7.
Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):441-7.
Andreasen N, Gottfries J, Vanmechelen E, Vanderstichele H, Davidson P, Blennow K, Rosengren L, Blennow K. Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):557-8. ,
McKracken E, Graham DI, Nilsen M, Stewart J, Nicoll JA, Horsburgh K. 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 2001 Oct;11(4):414-21.
Kitabayashi Y, Ueda H, Narumoto J, Nakamura K, Kita H, Fukui K. Qualitative analyses of clock drawings in Alzheimer's disease and vascular dementia. Psychiatry Clin Neurosci. 2001 Oct;55(5):485-91.
Kitabayashi Y, Ueda H, Tsuchida H, Iizumi H, Narumoto J, Nakamura K, Kita H, Fukui K. Relationship between regional cerebral blood flow and verbal fluency in Alzheimer's disease. Psychiatry Clin Neurosci. 2001 Oct;55(5):459-63.
Maki PM, Resnick SM. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage. 2001 Oct;14(4):789-801.
Fortini ME. Notch and presenilin: a proteolytic mechanism emerges. Curr Opin Cell Biol. 2001 Oct;13(5):627-34.
Skovronsky DM, Fath S, Lee VM, Milla ME. Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. J Neurobiol. 2001 Oct;49(1):40-6.
Yoshida S, Iwabuchi Y, Numachi Y, Saito H, Yamazaki H, Sakai H, Kimura M, Matsuoka H, Sato M. Clinical features and alterations in the inferior horn sizes in lateral ventricle in Alzheimer's patients with different ApoE genotype in Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct;25(7):1377-84.
Niizato K, Genda K, Nakamura R, Iritani S, Ikeda K. Cognitive decline in schizophrenics with Alzheimer's disease: a mini-review of neuropsychological and neuropathological studies. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct;25(7):1359-66.
Allison AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct;25(7):1341-57.
Janke AL, Zubicaray Gd , Rose SE, Griffin M, Chalk JB, Galloway GJ. 4D deformation modeling of cortical disease progression in Alzheimer's dementia. Magn Reson Med. 2001 Oct;46(4):661-6.
Kogan EA, Korczyn AD, Virchovsky RG, Klimovizky SS, Treves TA, Neufeld MY. EEG changes during long-term treatment with donepezil in Alzheimer's disease patients. J Neural Transm. 2001 Oct;108(10):1167-73.
Kim KW, Jhoo JH, Lee JH, Lee KU, Lee DY, Youn JC, Youn JY, Woo JI. Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans. J Neural Transm. 2001 Oct;108(10):1159-66.
Head E, Garzon-Rodriguez W, Johnson JK, Lott IT, Cotman CW, Glabe C. Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome. Neurobiol Dis. 2001 Oct;8(5):792-806.
Ghribi O, Herman MM, Forbes MS, DeWitt DA, Savory J. GDNF protects against aluminum-induced apoptosis in rabbits by upregulating Bcl-2 and Bcl-XL and inhibiting mitochondrial Bax translocation. Neurobiol Dis. 2001 Oct;8(5):764-73.
Mikros E, Benaki D, Humpfer E, Spraul M, Loukas S, Stassinopoulou CI, Pelecanou M. High-Resolution NMR Spectroscopy of the beta-Amyloid(1-28) Fibril Typical for Alzheimer's Disease. Angew Chem Int Ed Engl. 2001 Oct 1;40(19):3603-3605.
Yagami T, Ueda K, Asakura K, Sakaeda T, Kuroda T, Hata S, Kambayashi Y, Fujimoto M. Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloid beta protein-induced neuronal cell death. Br J Pharmacol. 2001 Oct;134(3):673-81.
Nagao M, Murase K, Kikuchi T, Ikeda M, Nebu A, Fukuhara R, Sugawara Y, Miki H, Ikezoe J. Fractal analysis of cerebral blood flow distribution in Alzheimer's disease. J Nucl Med. 2001 Oct;42(10):1446-50.
Nakano S, Asada T, Matsuda H, Uno M, Takasaki M. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med. 2001 Oct;42(10):1441-5.
Hock BJ, Lamb BT. Transgenic mouse models of Alzheimer's disease. Trends Genet. 2001 Oct;17(10):S7-12.
Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT, Chang TY, Tanzi RE, Kovacs DM. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol. 2001 Oct;3(10):905-12. ,
Gobburu JV, Tammara V, Lesko L, Jhee SS, Sramek JJ, Cutler NR, Yuan R. Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease. J Clin Pharmacol. 2001 Oct;41(10):1082-90.
Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF. Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol. 2001 Oct 1;154(7):642-8.
Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001 Oct 1;154(7):635-41.
Heidary G, Fortini ME. Identification and characterization of the Drosophila tau homolog. Mech Dev. 2001 Oct;108(1-2):171-8.
Gold G, Kövari E, Corte G, Herrmann FR, Canuto A, Bussière T, Hof PR, Bouras C, Giannakopoulos P. Clinical validity of A beta-protein deposition staging in brain aging and Alzheimer disease. J Neuropathol Exp Neurol. 2001 Oct;60(10):946-52.
Minger SL, Honer WG, Esiri MM, McDonald B, Keene J, Nicoll JA, Carter J, Hope T, Francis PT. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol. 2001 Oct;60(10):929-36.
Sequeira S. Early progression of Alzheimer's disease detected by MRI. Trends Neurosci. 2001 Oct;24(10):569.
Lendon C, Craddock N. Susceptibility gene(s) for Alzheimer's disease on chromosome 10. Trends Neurosci. 2001 Oct;24(10):557-9.
Gurwitz D. Immunization for Alzheimer's disease: yet closer to clinical trials. Trends Immunol. 2001 Oct;22(10):542-3.
Artinian LR, Ding JM, Gillette MU. Carbon monoxide and nitric oxide: interacting messengers in muscarinic signaling to the brain's circadian clock. Exp Neurol. 2001 Oct;171(2):293-300.
Olson JM, Goddard KA, Dudek DM. The amyloid precursor protein locus and very-late-onset Alzheimer disease. Am J Hum Genet. 2001 Oct;69(4):895-9.
Altmann LJ, Kempler D, Andersen ES. Speech errors in Alzheimer's disease: reevaluating morphosyntactic preservation. J Speech Lang Hear Res. 2001 Oct;44(5):1069-82.
Maguir-Zeis KA, Bowers WJ, Federoff HJ. HSV vector-mediated gene delivery to the central nervous system. Curr Opin Mol Ther. 2001 Oct;3(5):482-90.
Martin-Rendon E, Azzouz M, Mazarakis ND. Lentiviral vectors for the treatment of neurodegenerative diseases. Curr Opin Mol Ther. 2001 Oct;3(5):476-81.
Perry NS, Houghton PJ, Sampson J, Theobald AE, Hart S, Lis-Balchin M, Hoult JR, Evans P, Jenner P, Milligan S, Perry EK. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J Pharm Pharmacol. 2001 Oct;53(10):1347-56.
Thome J, Retz W, Baader M, Pesold B, Hu M, Cowen M, Durany N, Adler G, Henn FA, Rösler M. Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease. J Neural Transm. 2001 Oct;108(10):1175-80.
López-Pousa S, Vilalta-Franch J, Garre-Olmo J, Turon-Estrada A, Lozano-Gallego M, Hernàndez-Ferràndiz M, Fajardo-Tibau C, Cruz-Reina MM. [Effectiveness of donepezil on several cognitive functions in patients with Alzheimer's disease over 12 months] Neurologia. 2001 Oct;16(8):342-7.
Tran MH, Yamada K, Nabeshima T. Molecular mechanism of cholinergic dysfunction and cognitive deficits induced by amyloid beta-peptide. Nihon Shinkei Seishin Yakurigaku Zasshi. 2001 Oct;21(4):125-32.
Zhou B, Hong Z, Huang M. [Prevalence of dementia in Shanghai urban and rural area] Zhonghua Liu Xing Bing Xue Za Zhi. 2001 Oct;22(5):368-71.
Hong X, Zhang X, Li H. [A case-control study of endogenous estrogen and risk of Alzheimer's disease] Zhonghua Liu Xing Bing Xue Za Zhi. 2001 Oct;22(5):379-82.
Peng D, Xu X, Feng Y. [Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease] Zhonghua Nei Ke Za Zhi. 2001 Oct;40(10):688-90.
Wolfe MS. gamma-Secretase inhibitors as molecular probes of presenilin function. J Mol Neurosci. 2001 Oct;17(2):199-204.
Steiner H, Haass C. Nuclear signaling: a common function of presenilin substrates? J Mol Neurosci. 2001 Oct;17(2):193-8.
Hartmann D, Tournoy J, Saftig P, Annaert W, De Strooper B. Implication of APP secretases in notch signaling. J Mol Neurosci. 2001 Oct;17(2):171-81.
Vassar R. The beta-secretase, BACE: a prime drug target for Alzheimer's disease. J Mol Neurosci. 2001 Oct;17(2):157-70.
Holtzman DM. Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J Mol Neurosci. 2001 Oct;17(2):147-55.
Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci. 2001 Oct;17(2):137-45.
Bertram L, Tanzi RE. Dancing in the dark? The status of late-onset Alzheimer's disease genetics. J Mol Neurosci. 2001 Oct;17(2):127-36.
Galasko D. Biological markers and the treatment of Alzheimer's disease. J Mol Neurosci. 2001 Oct;17(2):119-25.
Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci. 2001 Oct;17(2):101-18.
Schenk D, Games D, Seubert P. Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization. J Mol Neurosci. 2001 Oct;17(2):259-67.
Wong PC, Cai H, Borchelt DR, Price DL. Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics. J Mol Neurosci. 2001 Oct;17(2):233-57.
Kotzbauer PT, Trojanowsk JQ, Lee VM. Lewy body pathology in Alzheimer's disease. J Mol Neurosci. 2001 Oct;17(2):225-32.
Mattson MP, Chan SL. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J Mol Neurosci. 2001 Oct;17(2):205-24.
Sabbagh MN, Reid RT, Hansen LA, Alford M, Thal LJ. Correlation of nicotinic receptor binding with clinical and neuropathological changes in Alzheimer's disease and dementia with Lewy bodies. J Neural Transm. 2001 Oct;108(10):1149-57.
Serra JA, Domínguez RO, de Lustig ES, Guareschi EM, Famulari AL, Bartolomé EL, Marschoff ER. Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients. J Neural Transm. 2001 Oct;108(10):1135-48.
Slosman DO, Ludwig C, Zerarka S, Pellerin L, Chicherio C, de Ribaupierre A, Annoni JM, Bouras C, Herrmann F, Michel JP, Giacobini E, Magistretti PJ. Brain energy metabolism in Alzheimer's disease: 99mTc-HMPAO SPECT imaging during verbal fluency and role of astrocytes in the cellular mechanism of 99mTc-HMPAO retention. Brain Res Brain Res Rev. 2001 Oct;36(2-3):230-40.
Amatore C, Arbault S, Bruce D, de Oliveira P, Erard LM, Vuillaume M. Characterization of the electrochemical oxidation of peroxynitrite: relevance to oxidative stress bursts measured at the single cell level. Chemistry. 2001 Oct 1;7(19):4171-9.
Rigaud AS, Traykov L, Caputo L, Coste J, Latour F, Couderc R, Moulin F, Boller F, Forette F. Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology. 2001 Oct;20(4):268-72.
Kagan BL, Hirakura Y, Azimov R, Azimova R. The channel hypothesis of Huntington's disease. Brain Res Bull. 2001 Oct-Nov 1;56(3-4):281-4.
Nicolaou M, Song YQ, Sato CA, Orlacchio A, Kawarai T, Medeiros H, Liang Y, Sorbi S, Richard E, Rogaev EI, Moliaka Y, Bruni AC, Jorge R, Percy M, Duara R, Farrer LA, St Georg-Hyslop P, Rogaeva EA. Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease. Neurogenetics. 2001 Oct;3(4):203-6. , ,
Deegan R, Bailey KP. To treat or not to treat? Managing acute symptoms in an elderly patient with Alzheimer's disease. J Psychosoc Nurs Ment Health Serv. 2001 Oct;39(10):12-5.
Wahl MJ. Amalgam--resurrection and redemption. Part 2: The medical mythology of anti-amalgam. Quintessence Int. 2001 Oct;32(9):696-710.
Sugaya K. [Glial activation and brain aging] Nippon Yakurigaku Zasshi. 2001 Oct;118(4):251-7.
Ferrer I, Blanco R, Carmona M, Puig B. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Neuropathol Appl Neurobiol. 2001 Oct;27(5):343-51.
Greene JR, Radenahmad N, Wilcock GK, Neal JW, Pearson RC. Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease. Neuropathol Appl Neurobiol. 2001 Oct;27(5):339-42.
Li H, Shen X, Chen Y. Spatial learning deficits in amyloid precursor protein 770 transgenic mice. Chin Med J (Engl). 2001 Oct;114(10):1060-3.
Akins PT. Does mild cognitive impairment represent early-stage Alzheimer disease? Arch Neurol. 2001 Oct;58(10):1705-6.
Tierney MC, Black SE, Szalai JP, Snow WG, Fisher RH, Nadon G, Chui HC. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol. 2001 Oct;58(10):1654-9.
Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol. 2001 Oct 1;58(10):1640-6.
Sencakova D, Graff-Radford NR, Willis FB, Lucas JA, Parfitt F, Cha RH, O'Brien PC, Petersen RC, Jack CR. Hippocampal atrophy correlates with clinical features of Alzheimer disease in African Americans. Arch Neurol. 2001 Oct;58(10):1593-7.
Zhu X, Rottkamp CA, Hartzler A, Sun Z, Takeda A, Boux H, Shimohama S, Perry G, Smith MA. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J Neurochem. 2001 Oct;79(2):311-8.
Ruiz-León Y, Pascual A. Brain-derived neurotrophic factor stimulates beta-amyloid gene promoter activity by a Ras-dependent/AP-1-independent mechanism in SH-SY5Y neuroblastoma cells. J Neurochem. 2001 Oct;79(2):278-85.
Watanabe K, Segawa T, Nakamura K, Kodaka M, Konakahara T, Okuno H. Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay. J Pept Res. 2001 Oct;58(4):342-6.
Nunan J, Shearman MS, Checler F, Cappai R, Evin G, Beyreuther K, Masters CL, Small DH. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur J Biochem. 2001 Oct;268(20):5329-36.
Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA. An automated technique for measuring hippocampal volumes from MR imaging studies. AJNR Am J Neuroradiol. 2001 Oct;22(9):1686-9.
Ohnishi T, Matsuda H, Tabira T, Asada T, Uno M. Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol. 2001 Oct;22(9):1680-5.
Dobrogowska DH, Vorbrodt AW, Wegiel J, Wang KC, Shoji M, Mondadori C, Polatis G, Giovanni A, Wisniewski HM. Cytochemical study of the involvement of cell organelles in formation and accumulation of fibrillar amyloid in the pancreas of NORbeta transgenic mice. Histol Histopathol. 2001 Oct;16(4):1047-56.
Neumann M, Schulz-Schaeffer W, Crowther RA, Smith MJ, Spillantini MG, Goedert M, Kretzschmar HA. Pick's disease associated with the novel Tau gene mutation K369I. Ann Neurol. 2001 Oct;50(4):503-13.
Liu WK, Le TV, Adamson J, Baker M, Cookson N, Hardy J, Hutton M, Yen SH, Dickson DW. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol. 2001 Oct;50(4):494-502.
Carter DB, Dunn E, McKinley DD, Stratman NC, Boyle TP, Kuiper SL, Oostveen JA, Weaver RJ, Boller JA, Gurney ME. Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. Ann Neurol. 2001 Oct;50(4):468-75.
Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol. 2001 Oct;50(4):434-42.
Popescu BO, Cedazo-Minguez A, Popescu LM, Winblad B, Cowburn RF, Ankarcrona M. Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cells. J Neurosci Res. 2001 Oct 1;66(1):122-34.
Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, Popiel AH, Sinohara A, Iwamatsu A, Kimura Y, Uchiyama Y, Hori S, Kakizuka A. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 2001 Oct;8(10):977-84.
Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL. Improving influence of insulin on cognitive functions in humans. Neuroendocrinology. 2001 Oct;74(4):270-80.
Ramírez-Expósito MJ, Robert-Baudouy J, Mayas MD, García MJ, Ramírez M, Martínez-Martos JM. Acetylcholinesterase inhibitor SDZ ENA 713 (Rivastigmine) increases brain pyrrolidone carboxyl peptidase activity. Eur Neuropsychopharmacol. 2001 Oct;11(5):381-3.
Ríos C, Pascual LF, Santos S, López E, Fernández T, Navas I, Casadevall T, Tejero C, Morales F. [Working memory and complex activities of everyday life in the initial stages of Alzheimer's disease] Rev Neurol. 2001 Oct 16-31;33(8):719-22.
Serrano-Sánchez T, Díaz-Armesto I. [Participation of interleukin 1 and interleukin 6 in the aetiopathogenesis of Alzheimer's disease] Rev Neurol. 2001 Oct 1-15;33(7):648-52.
Serrano C, Allegri RF, Drake M, Butman J, Harris P, Nagle C, Ranalli C. [A shortened form of the Spanish Boston naming test: a useful tool for the diagnosis of Alzheimer's disease] Rev Neurol. 2001 Oct 1-15;33(7):624-7.
Forsell C, Enmark E, Axelman K, Blomberg M, Wahlund LO, Gustafsson JA, Lannfelt L. Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease. Eur J Hum Genet. 2001 Oct;9(10):802-4. ,
Carlesimo GA, Mauri M, Fadda L, Turriziani P, Caltagirone C. Intact cross-modality text-specific repetition priming in patients with Alzheimer's disease. J Clin Exp Neuropsychol. 2001 Oct;23(5):569-80.
Chiu L, Shyu WC. Estimation of the family cost of private nursing home care versus home care for patients with dementia in Taiwan. Chang Gung Med J. 2001 Oct;24(10):608-14.
Faust ME, Balota DA, Spieler DH. Building episodic connections: changes in episodic priming with age and dementia. Neuropsychology. 2001 Oct;15(4):626-37.
Lazzara MM, Yonelinas AP, Ober BA. Conceptual implicit memory performance in Alzheimer's disease. Neuropsychology. 2001 Oct;15(4):483-91.
Vertesi A, Lever JA, Molloy DW, Sanderson B, Tuttle I, Pokoradi L, Principi E. Standardized Mini-Mental State Examination. Use and interpretation. Can Fam Physician. 2001 Oct;47:2018-23.
Fornazzari L, Cumsille F, Quevedo F, Quiroga P, Rioseco P, Klaasen G, Martinez CG, Rhode G, Sacks C, Rivera E, Gassic I, Hammersley F, Hoppe A, Arriagada P, Flaskamp R. Spanish validation of the Syndrom Kurztest (SKT). Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):211-5.
Volicer L, Hurley AC, Blasi ZV. Scales for evaluation of End-of-Life Care in Dementia. Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):194-200.
Peters R. The prevention of dementia. J Cardiovasc Risk. 2001 Oct;8(5):253-6.
Stevens A, Kircher T, Nickola M, Bartels M, Rosellen N, Wormstall H. Dynamic regulation of EEG power and coherence is lost early and globally in probable DAT. Eur Arch Psychiatry Clin Neurosci. 2001 Oct;251(5):199-204.
Leowattana W. DHEA(S): the fountain of youth. J Med Assoc Thai. 2001 Oct;84 Suppl 2:S605-12.
Fitten LJ, Ortiz F, Pontón M. Frequency of Alzheimer's disease and other dementias in a community outreach sample of Hispanics. J Am Geriatr Soc. 2001 Oct;49(10):1301-8.
Sultzer DL, Gray KF, Gunay I, Wheatley MV, Mahler ME. Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia? J Am Geriatr Soc. 2001 Oct;49(10):1294-300.
Feki M, Souissi M, Mebazaa A. [In Process Citation] Ann Med Interne (Paris). 2001 Oct;152(6):398-406.
Nobili A, Ricci A, Merli MR, Fasolino A, Cassinesi N, Tettamanti M, Gruppo Verifica e Revisione della Qualità (VRQ) del Pio Albergo Trivulzio. [Assessment of the relationship between health personnel and caregivers caring for dementia patients. Results of a pilot survey] Assist Inferm Ric. 2001 Oct-Dec;20(4):211-9.
Corsico A, McGuffin P. Psychiatric genetics: recent advances and clinical implications. Epidemiol Psichiatr Soc. 2001 Oct-Dec;10(4):253-9.
Mbebi C, See V, Mercken L, Pradier L, Loeffler J. [APP: a membrane receptor that mediates programmed cell death] Rev Neurol (Paris). 2001 Oct;157 Suppl 10:48.
Nelson LD, Orme D, Osann K, Lott IT. Neurological changes and emotional functioning in adults with Down Syndrome. J Intellect Disabil Res. 2001 Oct;45(Pt 5):450-6.
Keene J, Hope T, Fairburn CG, Jacoby R. Death and dementia. Int J Geriatr Psychiatry. 2001 Oct;16(10):969-74.
Purandare N, Burns A, Craig S, Faragher B, Scott K. Depressive symptoms in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2001 Oct;16(10):960-4.
Schreiner AS, Morimoto T, Asano H. Depressive symptoms among poststroke patients in Japan: frequency distribution and factor structure of the GDS. Int J Geriatr Psychiatry. 2001 Oct;16(10):941-9.
Fehder WP, Douglas SD. Interactions between the nervous and immune systems. Semin Clin Neuropsychiatry. 2001 Oct;6(4):229-40.
Mega MS. The entorhinal cortex in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):431-2.
Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol. 2001 Oct;112(10):1860-7.
Metitieri T, Zanetti O, Geroldi C, Frisoni GB, De Leo D, Dello Buono M, Bianchetti A, Trabucchi M. Reality orientation therapy to delay outcomes of progression in patients with dementia. A retrospective study. Clin Rehabil. 2001 Oct;15(5):471-8.
Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2001 Oct;8(5):890-9. ,
Irizarry MC, Hyman BT. Alzheimer disease therapeutics. J Neuropathol Exp Neurol. 2001 Oct;60(10):923-8.
Stewart R. NICE guidelines and the treatment of Alzheimer's disease: evidence-based medicine may be discriminatory. Br J Psychiatry. 2001 Oct;179:367.
Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 2001 Oct 1;359(Pt 1):1-16.
Sodeyama N, Iwata T, Ishikawa K, Mizusawa H, Yamada M, Itoh Y, Otomo E, Matsushita M, Komatsuzaki Y. Very early onset Alzheimer's disease with spastic paraparesis associated with a novel presenilin 1 mutation (Phe237Ile). J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):556-7. ,
Nagahama Y, Okina T, Nabatame H, Matsuda M, Murakami M. [Clock drawing in dementia: its reliability and relation to the neuropsychological measures] Rinsho Shinkeigaku. 2001 Oct;41(10):653-8.
John J, George N. Alzheimer's disease. Nurs J India. 2001 Oct;92(10):221-2.
Stratone A, Stratone C, Chiruta R, Topoliceanu F. [In Process Citation] Rev Med Chir Soc Med Nat Iasi. 2001 Oct-Dec;105(4):657-61.
Feldman H, Gabathuler R, Kennard M, Nurminen J, Levy D, Foti S, Foti D, Beattie BL, Jefferies WA. Serum p97 levels as an aid to identifying Alzheimer's disease. J Alzheimers Dis. 2001 Oct;3(5):507-516. ,
Scheff SW, Price DA. Alzheimer's disease-related synapse loss in the cingulate cortex. J Alzheimers Dis. 2001 Oct;3(5):495-505.
Xia Y, Saitoh T, Uéda K, Tanaka S, Chen X, Hashimoto M, Hsu L, Conrad C, Sundsmo M, Yoshimoto M, Thal L, Katzman R, Masliah E. Characterization of the human alpha-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms. J Alzheimers Dis. 2001 Oct;3(5):485-494. ,
Connor JR, Milward EA, Moalem S, Sampietro M, Boyer P, Percy ME, Vergani C, Scott RJ, Chorney M. Is hemochromatosis a risk factor for Alzheimer's disease? J Alzheimers Dis. 2001 Oct;3(5):471-477.
Chen SG. Molecular profiling of paired helical filamentsCommentary on: Quantitative assessment of glycolipid and protein associated with paired helical filament preparations from Alzheimer's diseased brain by Warren J. Goux, Bingcam Liu, Abdurahman M. Shumburo, Samir Parikh and Dennis R. Sparkman. J Alzheimers Dis. 2001 Oct;3(5):467-469.
Goux WJ, Liu B, Shumburo AM, Parikh S, Sparkman DR. A quantitative assessment of glycolipid and protein associated with paired helical filament preparations from Alzheimer's diseased brain. J Alzheimers Dis. 2001 Oct;3(5):455-466.
Ruben GC. CommentaryCommentary on: The Characterization by Atomic Force Microscopy and Cryoelectron Microscopy of Tau Polymers assembled in Alzheimer's disease. J Alzheimers Dis. 2001 Oct;3(5):453-454.
Moreno-Herrero F, Valpuesta JM, Pérez M, Colchero J, Barö AM, Avila J, Montejo De Garcini E. Characterization by atomic force microscopy and cryoelectron microscopy of tau polymers assembled in Alzheimer's disease. J Alzheimers Dis. 2001 Oct;3(5):443-451.
Lidström AM, Hesse C, Rosengren L, Fredman P, Davidsson P, Blennow K. Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke. J Alzheimers Dis. 2001 Oct;3(5):435-442.
No comments:
Post a Comment